H. Köppler
Impact in
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Hematology 21
- Acute Myeloid Leukemia Research 10
- Chronic Myeloid Leukemia Treatments 8
- Genetics 19
- Chronic Lymphocytic Leukemia Research 17
- Co-authors
- Rudolf Weide (37 shared papers)Jochen Heymanns (33 shared papers)Klaus HAVEMANN (18 shared papers)Jörg Thomalla (20 shared papers)Karl-Heinz Pflüger (12 shared papers)Wolfgang Hiddemann (4 shared papers)Neil Wintfeld (2 shared papers)Christoph J. Losem (2 shared papers)
- Journals
- Blood (5 papers)British Journal of Haematology (4 papers)Annals of Hematology (3 papers)Annals of Oncology (2 papers)Immunobiology (2 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
H. Köppler
65 papers receiving 1.7k citations
H. Köppler's Hit Papers
Peers
Comparison fields: 5 of 79
- Genetics 931
- Pathology and Forensic Medicine 827
- Hematology 367
- Oncology 420
- Immunology 332
Countries citing papers authored by H. Köppler
This map shows the geographic impact of H. Köppler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Köppler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Köppler more than expected).
Fields of papers citing papers by H. Köppler
This network shows the impact of papers produced by H. Köppler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Köppler. The network helps show where H. Köppler may publish in the future.
Co-authors
The 25 scholars most cited alongside H. Köppler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial Hit paper breakdown → | 2016 | 497 |
| 2 | 2002 | 113 | |
| 3 | 2014 | 97 | |
| 4 | 2007 | 82 | |
| 5 | 2003 | 77 | |
| 6 | 2004 | 54 | |
| 7 | 2013 | 48 | |
| 8 | 1992 | 38 | |
| 9 | Altered expression of the retinoblastoma gene product in human high grade non-Hodgkin's lymphomas. | 1994 | 37 |
| 10 | 2014 | 37 | |
| 11 | 1994 | 35 | |
| 12 | 2008 | 33 | |
| 13 | 2010 | 32 | |
| 14 | 2000 | 32 | |
| 15 | 1993 | 29 | |
| 16 | 2004 | 28 | |
| 17 | 2010 | 27 | |
| 18 | 1996 | 26 | |
| 19 | 2014 | 26 | |
| 20 | 1994 | 25 |
About H. Köppler
H. Köppler is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Public Health, Environmental and Occupational Health, having authored 71 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (20 papers), Chronic Lymphocytic Leukemia Research (17 papers), Acute Myeloid Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (8 papers), Chronic Myeloid Leukemia Treatments (8 papers), Histone Deacetylase Inhibitors Research (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Neutropenia and Cancer Infections (4 papers). The work is most often cited by research in Genetics (931 citations), Pathology and Forensic Medicine (827 citations), Hematology (367 citations), Oncology (420 citations) and Immunology (332 citations). H. Köppler has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Rudolf Weide, Jochen Heymanns, Klaus HAVEMANN, Jörg Thomalla, Karl-Heinz Pflüger, Wolfgang Hiddemann, Neil Wintfeld, Christoph J. Losem, Michael Robert Smith and W. B. Schwerk. Their work appears in journals such as Blood, British Journal of Haematology, Annals of Hematology, Annals of Oncology and Immunobiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.